SCHEMBL1628804

SCHEMBL1628804

COc1cc(OC)c(S(=O)(=O)N2CCCCC2)cc1-c1ccnn1-c1ccccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.52
ALDH1A1 P00352 6/20 0.52
GAA P10253 2/20 0.52
NPBWR1 P48145 1/20 0.52
KDM4E B2RXH2 2/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
MCOLN3 Q8TDD5 2/20 0.45
LMNA P02545 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TP53 P04637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 1/20 0.42
RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630245 0.91 TSHR (0.48) TSHRALDH1A1GAAKDM4EKMT2A
SCHEMBL1628573 0.86 CYP19A1 (0.41) TSHRALDH1A1GAANPBWR1KDM4E
SCHEMBL1219165 0.86 HSP90AA1 (0.40) TSHRALDH1A1GAALMNASMN1; SMN2
SCHEMBL1628788 0.85 HSP90AA1 (0.41) TSHRALDH1A1LMNASMN1; SMN2TP53
SCHEMBL1630418 0.85 HSP90AA1 (0.41) TSHRALDH1A1KMT2ALMNASMN1; SMN2
SCHEMBL1629183 0.84 OPRM1 (0.40) TSHRALDH1A1GAANPBWR1KDM4E
SCHEMBL1631566 0.83 TSHR (0.44) TSHRALDH1A1LMNASMN1; SMN2TP53
SCHEMBL1631546 0.83 HSP90AA1 (0.40) ALDH1A1LMNASMN1; SMN2TP53MAPK1
SCHEMBL1630408 0.82 HSP90AA1 (0.50) TSHRALDH1A1GAAKDM4ERAB9A
SCHEMBL1628849 0.82 MEN1 (0.45) TSHRALDH1A1GAAKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P TSHR 1658/4885ALDH1A1 777/4885GAA 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.